Deal Intelligence Report

Generated: 2026-02-16 12:10 UTC

🔥 Top 5 Actions This Week

1. GNAL (€20,500,000)

Stage: Qualification | 5% | Assignee: Simon Wolpert
Days since contact: 17 | Urgency: 2
🔍 Find DM: Suggested titles to target at GNAL: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

2. VA (EHR Modernization Integration Office) (€15,336,649)

Stage: Qualification | Assignee: Simon Wolpert
Days since contact: 656 | Urgency: 2
🔍 Find DM: Suggested titles to target at VA (EHR Modernization Integration Office): VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

3. Malaffi Super App (€8,000,000)

Stage: Qualification | Assignee: Simon Wolpert
Days since contact: 8 | Urgency: 2
🔍 Find DM: Suggested titles to target at Malaffi Super App: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

4. AstraZeneca | aHUS, PNH, HPP | UAE - Phase 2 (€5,056,038)

Stage: Qualification | 5% | Assignee: Eran Desheh
Days since contact: 23 | Urgency: 3
📞 Re-engage: AstraZeneca | aHUS, PNH, HPP | UAE just FDA rejected subcutaneous Saphnelo for lupus; targeting $80B revenue by 2030 with products like baxdrostat (hypertension), camizestrant (breast cancer. Draft outreach?
👤 Follow up with Christina Duran

5. AstraZeneca | ATTR-CM | UAE - Phase 2 (€5,056,038)

Stage: Qualification | 5% | Assignee: Eran Desheh
Days since contact: 23 | Urgency: 3
📞 Re-engage: AstraZeneca | ATTR-CM | UAE just FDA rejected subcutaneous Saphnelo for lupus; targeting $80B revenue by 2030 with products like baxdrostat (hypertension), camizestrant (breast cancer. Draft outreach?
👤 Follow up with Christina Duran

All Deal Recommendations

GNAL (€20,500,000) — Score: 41,000,000

Stage: Qualification | 5% | Assignee: Simon Wolpert | Days silent: 17

[find-dm] Find DM: Suggested titles to target at GNAL: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

VA (EHR Modernization Integration Office) (€15,336,649) — Score: 30,673,297

Stage: Qualification | Assignee: Simon Wolpert | Days silent: 656

[find-dm] Find DM: Suggested titles to target at VA (EHR Modernization Integration Office): VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Malaffi Super App (€8,000,000) — Score: 16,000,000

Stage: Qualification | Assignee: Simon Wolpert | Days silent: 8

[find-dm] Find DM: Suggested titles to target at Malaffi Super App: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

AstraZeneca | aHUS, PNH, HPP | UAE - Phase 2 (€5,056,038) — Score: 15,168,114

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 23

[re-engage] Re-engage: AstraZeneca | aHUS, PNH, HPP | UAE just FDA rejected subcutaneous Saphnelo for lupus; targeting $80B revenue by 2030 with products like baxdrostat (hypertension), camizestrant (breast cancer. Draft outreach?
[follow-up-dm] Follow up with Christina Duran

AstraZeneca | ATTR-CM | UAE - Phase 2 (€5,056,038) — Score: 15,168,114

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 23

[re-engage] Re-engage: AstraZeneca | ATTR-CM | UAE just FDA rejected subcutaneous Saphnelo for lupus; targeting $80B revenue by 2030 with products like baxdrostat (hypertension), camizestrant (breast cancer. Draft outreach?
[follow-up-dm] Follow up with Christina Duran

Saudi MoH Sehhaty App (€7,085,000) — Score: 14,170,000

Stage: Qualification | Assignee: Daniel Nathrath | Days silent: 228

[find-dm] Find DM: Suggested titles to target at Saudi MoH Sehhaty App: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Ontario Upsell - FTI + Concierge (€7,000,000) — Score: 14,000,000

Stage: Qualification | Assignee: Simon Wolpert | Days silent: 268

[find-dm] Find DM: Suggested titles to target at Ontario Upsell: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Biogen | Friedreichs Ataxia | Global - Phase 2 (€6,000,000) — Score: 12,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 5

[opportunity-intel] Opportunity: Biogen | Friedreichs Ataxia | Global litifilimab (anti-dendritic cell) for cutaneous lupus. Relevance to Patient Finder: potential alignment with digital patient identification.

MSD | PAH | SOTATERCEPT | DE - Phase 2 (€6,000,000) — Score: 12,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 9

[find-dm] Find DM: Suggested titles to target at MSD | PAH | SOTATERCEPT | DE: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Blue Shield of California (€5,477,374) — Score: 10,954,749

Stage: Proposal | 30% | Assignee: Simon Wolpert | Days silent: 3

[find-dm] Find DM: Suggested titles to target at Blue Shield of California: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Blue Cross Blue Shield Michigan (€5,056,038) — Score: 10,112,076

Stage: Qualification | Assignee: Simon Wolpert | Days silent: 397

[find-dm] Find DM: Suggested titles to target at Blue Cross Blue Shield Michigan: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Risant Health Expansion [Entity C] (€5,056,038) — Score: 10,112,076

Stage: Qualification | 5% | Assignee: Eric Harker | Days silent: 275

[find-dm] Find DM: Suggested titles to target at Risant Health Expansion [Entity C]: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Risant Health Expansion [Entity D] (€5,056,038) — Score: 10,112,076

Stage: Qualification | 5% | Assignee: Eric Harker | Days silent: 275

[find-dm] Find DM: Suggested titles to target at Risant Health Expansion [Entity D]: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Risant Health Expansion [Entity E] (€5,056,038) — Score: 10,112,076

Stage: Qualification | 5% | Assignee: Eric Harker | Days silent: 275

[find-dm] Find DM: Suggested titles to target at Risant Health Expansion [Entity E]: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Risant Health Expansion [Entity F] (€5,056,038) — Score: 10,112,076

Stage: Qualification | 5% | Assignee: Eric Harker | Days silent: 275

[find-dm] Find DM: Suggested titles to target at Risant Health Expansion [Entity F]: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Takeda | Narcolepsy | investigational | US - Phase 2 (€5,056,038) — Score: 10,112,076

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 4

[find-dm] Find DM: Suggested titles to target at Takeda | Narcolepsy | investigational | US: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

UCB | TK2D | investigational | US - Phase 2 (€5,056,038) — Score: 10,112,076

Stage: Qualification | 5% | Assignee: Jacob Plummer | Days silent: 12

[find-dm] Find DM: Suggested titles to target at UCB | TK2D | investigational | US: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

VERTEX | AMKD | US - Phase 2 (€5,056,038) — Score: 10,112,076

Stage: Qualification | 5% | Assignee: Jacob Plummer | Days silent: 174

[find-dm] Find DM: Suggested titles to target at VERTEX | AMKD | US: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Alberta Health Services - Patient Portal (via Orion & Telus/IBM) (€4,795,791) — Score: 9,591,581

Stage: Qualification | 5% | Assignee: Simon Wolpert | Days silent: 100

[find-dm] Find DM: Suggested titles to target at Alberta Health Services: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Fraser Health (vis Deloitte) - British Columbia (€3,248,761) — Score: 6,497,523

Stage: Qualification | 5% | Assignee: Simon Wolpert | Days silent: 331

[find-dm] Find DM: Suggested titles to target at Fraser Health (vis Deloitte): VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

BCBSA (€3,200,000) — Score: 6,400,000

Stage: Qualification | Assignee: Simon Wolpert | Days silent: 472

[find-dm] Find DM: Suggested titles to target at BCBSA: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Resmed Phase 2 (€2,528,019) — Score: 5,056,038

Stage: Qualification | 5% | Assignee: Jacob Plummer | Days silent: 2

[find-dm] Find DM: Suggested titles to target at Resmed Phase 2: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

SANOFI | Diabetes | TZIELD | US - Phase 2 (€2,528,019) — Score: 5,056,038

Stage: Discovery | 10% | Assignee: Eran Desheh | Days silent: 3

[find-dm] Find DM: Suggested titles to target at SANOFI | Diabetes | TZIELD | US: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Biogen Germany FA extension (€2,100,000) — Score: 4,200,000

Stage: Discovery | 10% | Assignee: Eran Desheh | Days silent: 5

[opportunity-intel] Opportunity: Biogen Germany FA extension litifilimab (anti-dendritic cell) for cutaneous lupus. Relevance to Patient Finder: potential alignment with digital patient identification.

Ontario Enhancements (€1,980,197) — Score: 3,960,395

Stage: Proposal | 30% | Assignee: Simon Wolpert | Days silent: 19

[find-dm] Find DM: Suggested titles to target at Ontario Enhancements: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Salinas Valley Health (€1,700,000) — Score: 3,400,000

Stage: Qualification | Assignee: Simon Wolpert | Days silent: 754

[find-dm] Find DM: Suggested titles to target at Salinas Valley Health: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Blue Cross Blue Shield Arizona (€1,432,544) — Score: 2,865,088

Stage: Qualification | 5% | Assignee: Simon Wolpert | Days silent: 75

[find-dm] Find DM: Suggested titles to target at Blue Cross Blue Shield Arizona: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Highmark RFI (€1,432,544) — Score: 2,865,088

Stage: Qualification | 5% | Assignee: Simon Wolpert | Days silent: 205

[find-dm] Find DM: Suggested titles to target at Highmark RFI: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Main Line Health (€1,432,544) — Score: 2,865,088

Stage: Qualification | Assignee: Simon Wolpert | Days silent: 354

[find-dm] Find DM: Suggested titles to target at Main Line Health: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Stanford Health Care (€1,432,544) — Score: 2,865,088

Stage: Qualification | 5% | Assignee: Simon Wolpert | Days silent: 10

[find-dm] Find DM: Suggested titles to target at Stanford Health Care: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Newfoundland DFD (via Orion) (€1,361,386) — Score: 2,722,771

Stage: Discovery | 10% | Assignee: Simon Wolpert | Days silent: 8

[find-dm] Find DM: Suggested titles to target at Newfoundland DFD (via Orion): VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

NYU Langone DFD (€1,264,010) — Score: 2,528,019

Stage: Qualification | 5% | Assignee: Simon Wolpert | Days silent: 182

[find-dm] Find DM: Suggested titles to target at NYU Langone DFD: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Astrazeneca - Wainua (€500,000) — Score: 2,500,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 165

[re-engage] Re-engage: Astrazeneca just FDA rejected subcutaneous Saphnelo for lupus; targeting $80B revenue by 2030 with products like baxdrostat (hypertension), camizestrant (breast cancer. Draft outreach?
[follow-up-dm] Follow up with Christina Duran

Dubai Health (Phase 1) (€1,250,000) — Score: 2,500,000

Stage: Qualification | 5% | Assignee: Simon Wolpert | Days silent: 12

[find-dm] Find DM: Suggested titles to target at Dubai Health (Phase 1): VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

J&J - Invega (€500,000) — Score: 2,500,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 89

[re-engage] Re-engage: J&J just nipocalimab (FcRn) for Sjogren's. Draft outreach?
[find-dm] Find DM: Suggested titles to target at J&J: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

AbbVie - Botox (€421,336) — Score: 2,106,682

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 90

[re-engage] Re-engage: AbbVie just Submitted regulatory applications to FDA and EMA for upadacitinib (RINVOQ®) in vitiligo on February 3. Reported Q4 2025 financial results on February . Draft outreach?
[find-dm] Find DM: Suggested titles to target at AbbVie: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Novartis | drug tbd | US (€421,336) — Score: 2,106,682

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 119

[re-engage] Re-engage: Novartis | drug tbd | US just ianalumab (BAFF blockade) for Sjogren's. Draft outreach?
[find-dm] Find DM: Suggested titles to target at Novartis | drug tbd | US: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Pharmeon | UW Zorg online (€1,050,000) — Score: 2,100,000

Stage: Discovery | Assignee: | Days silent: 319

[find-dm] Find DM: Suggested titles to target at Pharmeon | UW Zorg online: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Clinical University Childrens Hospital, Latvia (BUKS) (€1,000,000) — Score: 2,000,000

Stage: Discovery | 10% | Assignee: Adel Baluch | Days silent: 20

[find-dm] Find DM: Suggested titles to target at Clinical University Childrens Hospital, Latvia (BUKS): VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Upsell - PHC / Agent (€1,000,000) — Score: 2,000,000

Stage: Qualification | 5% | Assignee: Simon Wolpert | Days silent: 33

[find-dm] Find DM: Suggested titles to target at Upsell: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Saudi MoH Saned platform (€900,000) — Score: 1,800,000

Stage: Qualification | Assignee: Daniel Nathrath | Days silent: 228

[find-dm] Find DM: Suggested titles to target at Saudi MoH Saned platform: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Incyte Jakafi Patient Finder (€421,336) — Score: 1,775,632

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 59

[re-engage] Re-engage: Incyte Jakafi Patient Finder just HC Wainwright initiated Buy coverage on February 5.. Draft outreach?
[find-dm] Find DM: Suggested titles to target at Incyte Jakafi Patient Finder: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

RVO Health (€842,673) — Score: 1,685,346

Stage: Proposal | 30% | Assignee: Jacob Plummer | Days silent: 3

[find-dm] Find DM: Suggested titles to target at RVO Health: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

HCF Hospitals Contribution Fund (€800,000) — Score: 1,600,000

Stage: Qualification | 5% | Assignee: Jacob Plummer | Days silent: 23

[find-dm] Find DM: Suggested titles to target at HCF Hospitals Contribution Fund: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Texas Tech University Health System (€758,406) — Score: 1,516,811

Stage: Qualification | Assignee: | Days silent: 1021

[find-dm] Find DM: Suggested titles to target at Texas Tech University Health System: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Biogen - leqembi (€500,000) — Score: 1,500,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 23

[re-engage] Re-engage: Biogen just litifilimab (anti-dendritic cell) for cutaneous lupus. Draft outreach?
[follow-up-dm] Follow up with Dr. Wolfram Schmidt

AstraZeneca | PNH | UAE (€421,336) — Score: 1,264,010

Stage: Discovery | 10% | Assignee: Eran Desheh | Days silent: 23

[re-engage] Re-engage: AstraZeneca | PNH | UAE just FDA rejected subcutaneous Saphnelo for lupus; targeting $80B revenue by 2030 with products like baxdrostat (hypertension), camizestrant (breast cancer. Draft outreach?
[follow-up-dm] Follow up with Christina Duran

Biogen US (€421,336) — Score: 1,264,010

Stage: Qualification | 5% | Assignee: Ashley Cudini | Days silent: 23

[re-engage] Re-engage: Biogen US just litifilimab (anti-dendritic cell) for cutaneous lupus. Draft outreach?
[follow-up-dm] Follow up with Dr. Wolfram Schmidt

NHS England (€575,015) — Score: 1,150,030

Stage: Discovery | 10% | Assignee: Adel Baluch | Days silent: 11

[find-dm] Find DM: Suggested titles to target at NHS England: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

AbbVie - Vraylar (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 23

[re-engage] Re-engage: AbbVie just Submitted regulatory applications to FDA and EMA for upadacitinib (RINVOQ®) in vitiligo on February 3. Reported Q4 2025 financial results on February . Draft outreach?
[find-dm] Find DM: Suggested titles to target at AbbVie: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Alexion Europe SAS - Voydeya (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 133

[find-dm] Find DM: Suggested titles to target at Alexion Europe SAS: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Alexion Pharmaceuticals - Koselugo (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 90

[find-dm] Find DM: Suggested titles to target at Alexion Pharmaceuticals: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Alexion Pharmaceuticals - Ultomiris (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Alexion Pharmaceuticals: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

ALK-Abelló A/S - Eurneffy (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at ALK-Abelló A/S: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Alkermes - Libalvi (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Alkermes: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Amgen - Evenity (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Amgen: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Amivas Ireland Ltd - Artesunate Amivas (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Amivas Ireland Ltd: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Angelini Pharma S.p.A - Ontozry (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Angelini Pharma S.p.A: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Astellas - MYRBETIQ (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 91

[find-dm] Find DM: Suggested titles to target at Astellas: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Astellas - VEOZAH (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 91

[find-dm] Find DM: Suggested titles to target at Astellas: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

AstraZeneca AB - Wainzua (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[opportunity-intel] Opportunity: AstraZeneca AB - Wainzua FDA rejected subcutaneous Saphnelo for lupus; targeting $80B revenue by 2030 with products like baxdrostat (hypertension. Relevance to Patient Finder: potential alignment with digital patient identification.

Biogen - Spinraza (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[opportunity-intel] Opportunity: Biogen litifilimab (anti-dendritic cell) for cutaneous lupus. Relevance to Patient Finder: potential alignment with digital patient identification.

Biogen - Vumerity (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 5

[opportunity-intel] Opportunity: Biogen litifilimab (anti-dendritic cell) for cutaneous lupus. Relevance to Patient Finder: potential alignment with digital patient identification.

BMS - Atrial fibrilation and thrombosis (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 233

[find-dm] Find DM: Suggested titles to target at BMS: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

BMS - Inrebic (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at BMS: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

BMS - Juvenile Idiopathic Arthritis (JIA) (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 233

[find-dm] Find DM: Suggested titles to target at BMS: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

BMS - Psoriatic arthritis (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 233

[find-dm] Find DM: Suggested titles to target at BMS: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

BMS - Rheumatoid arthritis (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 233

[find-dm] Find DM: Suggested titles to target at BMS: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

BMS - Zeposia (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 90

[find-dm] Find DM: Suggested titles to target at BMS: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Deciphera Pharmaceuticals (Netherlands) B.V. - Qinlock (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Deciphera Pharmaceuticals (Netherlands) B.V.: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Eli Lilly Nederland B.V. - Omvoh (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Eli Lilly Nederland B.V.: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Etsilat (€500,000) — Score: 1,000,000

Stage: Discovery | 10% | Assignee: Adel Baluch | Days silent: 11

[find-dm] Find DM: Suggested titles to target at Etsilat: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Galderma International - Nemluvio (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Galderma International: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Gedeon Richter Plc. - Ryeqo (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Gedeon Richter Plc.: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Genentech - Esbriet (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Genentech: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Genentech - Xolair (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Genentech: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

GlaxoSmithKline - Xevudy (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at GlaxoSmithKline: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

GlaxoSmithKline Trading Services Limited - Omjjara (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at GlaxoSmithKline Trading Services Limited: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

GSK - Arexvy (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at GSK: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Incyte Biosciences Distribution B.V. - Opzelura (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Incyte Biosciences Distribution B.V.: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer
[opportunity-intel] Opportunity: Incyte Biosciences Distribution B.V. HC Wainwright initiated Buy coverage on February 5.. Relevance to Patient Finder: potential alignment with digital patient identification.

InflaRx GmbH - Gohibic (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at InflaRx GmbH: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Janssen-Cilag International N.V. - Akeega (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Janssen-Cilag International N.V.: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Kyowa Kirin - Phase 1 (€500,000) — Score: 1,000,000

Stage: Discovery | 10% | Assignee: Eran Desheh | Days silent: 2

[find-dm] Find DM: Suggested titles to target at Kyowa Kirin: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Laboratoires Théa - Vevizye (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Laboratoires Théa: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

LEO Pharma A/S - Adtralza (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at LEO Pharma A/S: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

LEO Pharma A/S - Anzupgo (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at LEO Pharma A/S: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Medice Arzneimittel Pütter GmbH & Co. KG - Vafseo (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Medice Arzneimittel Pütter GmbH & Co. KG: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Merck - KEYTRUDA (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Merck: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Merck - Welireg (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Merck: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Ministry of National Guard Health Affairs (Saudi Arabia) (€500,000) — Score: 1,000,000

Stage: Discovery | 10% | Assignee: Adel Baluch | Days silent: 11

[find-dm] Find DM: Suggested titles to target at Ministry of National Guard Health Affairs (Saudi Arabia): VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Moderna Biotech Spain, S.L. - mResvia (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Moderna Biotech Spain, S.L.: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Mundipharma GmbH - Rezzayo (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Mundipharma GmbH: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Neuraxpharm Pharmaceuticals S.L. - Tuzulby (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Neuraxpharm Pharmaceuticals S.L.: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Norgine B.V. - Agilus (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Norgine B.V.: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Novartis Fabhalta Patient Finder (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 23

[re-engage] Re-engage: Novartis Fabhalta Patient Finder just ianalumab (BAFF blockade) for Sjogren's. Draft outreach?
[find-dm] Find DM: Suggested titles to target at Novartis Fabhalta Patient Finder: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Novartis Kesimpta Patient Finder (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 23

[re-engage] Re-engage: Novartis Kesimpta Patient Finder just ianalumab (BAFF blockade) for Sjogren's. Draft outreach?
[find-dm] Find DM: Suggested titles to target at Novartis Kesimpta Patient Finder: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Novo Nordisk A/S - Alhemo (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Novo Nordisk A/S: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Novo Nordisk A/S - Sogroya (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Novo Nordisk A/S: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Novo Nordisk A/S - Zegalogue (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Novo Nordisk A/S: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Novo Nordisk Global Markets (€500,000) — Score: 1,000,000

Stage: Discovery | 10% | Assignee: Eran Desheh | Days silent: 146

[find-dm] Find DM: Suggested titles to target at Novo Nordisk Global Markets: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Outlook Therapeutics Limited - Lytenava (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Outlook Therapeutics Limited: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Pfizer - Nurtec (€500,000) — Score: 1,000,000

Stage: Discovery | 10% | Assignee: Eran Desheh | Days silent: 5

[find-dm] Find DM: Suggested titles to target at Pfizer: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Pfizer Europe MA EEIG - Litfulo (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Pfizer Europe MA EEIG: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Pfizer Europe MA EEIG - Cibinqo (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Pfizer Europe MA EEIG - Cibinqo: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Pfizer Europe MA EEIG - Emblaveo (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Pfizer Europe MA EEIG - Emblaveo: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Pfizer Europe MA EEIG - Hympavzi (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Pfizer Europe MA EEIG - Hympavzi: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Pfizer Europe MA EEIG - Tivdak (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Pfizer Europe MA EEIG - Tivdak: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Pierre Fabre Medicament - Obgemsa (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Pierre Fabre Medicament: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Plusultra pharma GmbH - Hyftor (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Plusultra pharma GmbH: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Pure Health UAE (€500,000) — Score: 1,000,000

Stage: Discovery | 10% | Assignee: Adel Baluch | Days silent: 11

[find-dm] Find DM: Suggested titles to target at Pure Health UAE: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Roche - Piasky (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Roche: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Roche Registration GmbH - Xofluza (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Roche Registration GmbH: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Roche Registration GmbH - Ronapreve (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Roche Registration GmbH - Ronapreve: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Roche - Evrysdi (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Roche - Evrysdi: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Santen Oy - Catiolanze (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Santen Oy: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Santhera Pharmaceuticals (Deutschland) GmbH - Agamree (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Santhera Pharmaceuticals (Deutschland) GmbH: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Seqirus Netherlands B.V. - Fluad (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Seqirus Netherlands B.V.: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

SIFI SPA - Akantior (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at SIFI SPA: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Sumitomo - MYFEMBREE (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Sumitomo: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer
[opportunity-intel] Opportunity: Sumitomo Announced sale of Asian business to Marubeni for ~$480M. Q3 FY2025 financial results conference on February 2 showing re. Relevance to Patient Finder: potential alignment with digital patient identification.

Sumitomo - ORGOVYX (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Sumitomo: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer
[opportunity-intel] Opportunity: Sumitomo Announced sale of Asian business to Marubeni for ~$480M. Q3 FY2025 financial results conference on February 2 showing re. Relevance to Patient Finder: potential alignment with digital patient identification.

Swedish Orphan Biovitrum AB (publ) - Altuvoct (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Swedish Orphan Biovitrum AB (publ): VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Takeda - Alunbrig (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Takeda: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Takeda - Zasocitinib (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 90

[find-dm] Find DM: Suggested titles to target at Takeda: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Teva B.V. - BroPair Spiromax (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Teva B.V.: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Teva B.V. - Seffalair Spiromax (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Teva B.V.: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

UCB - Neupro (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at UCB: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

UCB Pharma S.A. - Bimzelx (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 12

[find-dm] Find DM: Suggested titles to target at UCB Pharma S.A. - Bimzelx: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Ultragenyx Germany GmbH - Evkeeza (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Ultragenyx Germany GmbH: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Vertex Pharmaceuticals (Ireland) Limited - Casgevy (€500,000) — Score: 1,000,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Vertex Pharmaceuticals (Ireland) Limited: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

DKV Seguros (€486,000) — Score: 972,000

Stage: Discovery | 10% | Assignee: Johannes Vonhuelsen | Days silent: 147

[find-dm] Find DM: Suggested titles to target at DKV Seguros: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

AbbVie - Rinvoq (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 23

[re-engage] Re-engage: AbbVie just Submitted regulatory applications to FDA and EMA for upadacitinib (RINVOQ®) in vitiligo on February 3. Reported Q4 2025 financial results on February . Draft outreach?
[find-dm] Find DM: Suggested titles to target at AbbVie: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

ACADIA Pharmaceuticals | Daybue | Rett syndrome (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 23

[find-dm] Find DM: Suggested titles to target at ACADIA Pharmaceuticals | Daybue | Rett syndrome: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Acorda Therapeutics | Ampyra | Multiple sclerosis (improve walking) (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Acorda Therapeutics | Ampyra | Multiple sclerosis (improve walking): VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Alnylam Pharmaceuticals | Amvuttra | ATTR-CM (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Ashley Cudini | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Alnylam Pharmaceuticals | Amvuttra | ATTR-CM: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

argenx US Vyvgart gMG (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Ashley Cudini | Days silent: 23

[find-dm] Find DM: Suggested titles to target at argenx US Vyvgart gMG: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

AstraZeneca - Breztri Aerosphere (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[opportunity-intel] Opportunity: AstraZeneca FDA rejected subcutaneous Saphnelo for lupus; targeting $80B revenue by 2030 with products like baxdrostat (hypertension. Relevance to Patient Finder: potential alignment with digital patient identification.
[opportunity-intel] Opportunity: AstraZeneca Recent reference to January 31 statement on UK-China collaboration and AstraZeneca's $15B investment in China by 2030.. Relevance to Patient Finder: potential alignment with digital patient identification.

AstraZeneca - Calquence (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[opportunity-intel] Opportunity: AstraZeneca FDA rejected subcutaneous Saphnelo for lupus; targeting $80B revenue by 2030 with products like baxdrostat (hypertension. Relevance to Patient Finder: potential alignment with digital patient identification.
[opportunity-intel] Opportunity: AstraZeneca Recent reference to January 31 statement on UK-China collaboration and AstraZeneca's $15B investment in China by 2030.. Relevance to Patient Finder: potential alignment with digital patient identification.

AstraZeneca - Farxiga (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[opportunity-intel] Opportunity: AstraZeneca FDA rejected subcutaneous Saphnelo for lupus; targeting $80B revenue by 2030 with products like baxdrostat (hypertension. Relevance to Patient Finder: potential alignment with digital patient identification.
[opportunity-intel] Opportunity: AstraZeneca Recent reference to January 31 statement on UK-China collaboration and AstraZeneca's $15B investment in China by 2030.. Relevance to Patient Finder: potential alignment with digital patient identification.

AstraZeneca | Saphnelo | Systemic lupus erythematosus (SLE) (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Jacob Plummer | Days silent: 0

[opportunity-intel] Opportunity: AstraZeneca | Saphnelo | Systemic lupus erythematosus (SLE) FDA rejected subcutaneous Saphnelo for lupus; targeting $80B revenue by 2030 with products like baxdrostat (hypertension. Relevance to Patient Finder: potential alignment with digital patient identification.

Bayer US - Lynkuet (Elinzanetant) (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 9

[find-dm] Find DM: Suggested titles to target at Bayer US: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Bayer US Nubeqa (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 9

[find-dm] Find DM: Suggested titles to target at Bayer US Nubeqa: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Bayer | ATTR-CM | DE (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Jacob Plummer | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Bayer | ATTR-CM | DE: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

BMS - US (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Jacob Plummer | Days silent: 23

[find-dm] Find DM: Suggested titles to target at BMS: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

BMS Cobenfy Patient Finder (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 86

[find-dm] Find DM: Suggested titles to target at BMS Cobenfy Patient Finder: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

BridgeBio Pharma | Attruby | ATTR-CM (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Ashley Cudini | Days silent: 93

[find-dm] Find DM: Suggested titles to target at BridgeBio Pharma | Attruby | ATTR-CM: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Bristol Myers Squibb | Opdivo | Melanoma (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 86

[find-dm] Find DM: Suggested titles to target at Bristol Myers Squibb | Opdivo | Melanoma: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Centene Patient Finder (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Jacob Plummer | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Centene Patient Finder: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Crohns Colitis Foundation (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Jacob Plummer | Days silent: 382

[find-dm] Find DM: Suggested titles to target at Crohns Colitis Foundation: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

EMD Serono | MS & Rare Disease | US (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 23

[find-dm] Find DM: Suggested titles to target at EMD Serono | MS & Rare Disease | US: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Genentach | Ocrevus (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Genentach | Ocrevus: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Gilead - Biktarvy (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Gilead: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer
[opportunity-intel] Opportunity: Gilead Q4 2025 financial results release on February 10. FDA approved label update for Yescarta in CNS lymphoma. Phase 3 result. Relevance to Patient Finder: potential alignment with digital patient identification.

Gilead - Descovy (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Gilead: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer
[opportunity-intel] Opportunity: Gilead Q4 2025 financial results release on February 10. FDA approved label update for Yescarta in CNS lymphoma. Phase 3 result. Relevance to Patient Finder: potential alignment with digital patient identification.

GSK - Arnuity Ellipta (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at GSK: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

GSK - Flovent (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at GSK: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

GSK - Shingrix (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 131

[find-dm] Find DM: Suggested titles to target at GSK: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Ipsen - Sohonos (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Ipsen: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Ipsen Patient Finder | Bylvay and Rare in Liver (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 3

[find-dm] Find DM: Suggested titles to target at Ipsen Patient Finder | Bylvay and Rare in Liver: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

J&J Immunology (Stelara) US - Phase 1 (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 23

[re-engage] Re-engage: J&J Immunology (Stelara) US just nipocalimab (FcRn) for Sjogren's. Draft outreach?
[find-dm] Find DM: Suggested titles to target at J&J Immunology (Stelara) US: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

J&J Immunology (Tremfya) US - Phase 1 (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 23

[re-engage] Re-engage: J&J Immunology (Tremfya) US just nipocalimab (FcRn) for Sjogren's. Draft outreach?
[find-dm] Find DM: Suggested titles to target at J&J Immunology (Tremfya) US: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Jazz Pharma (€421,336) — Score: 842,673

Stage: Qualification | Assignee: Ashley Cudini | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Jazz Pharma: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Jazz Pharmaceuticals US- Xywav (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Ashley Cudini | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Jazz Pharmaceuticals US- Xywav: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Johnson & Johnson | Tremfya | Psoriasis total (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Jacob Plummer | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Johnson & Johnson | Tremfya | Psoriasis total: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Madrigal - Rezdiffra (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Madrigal: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Merck - Gardasil 9 (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Merck: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Merck Patient Finder PAH(Oncology) Winrevair US (€421,336) — Score: 842,673

Stage: Discovery | 10% | Assignee: Karen VanOverberghe | Days silent: 2

[find-dm] Find DM: Suggested titles to target at Merck Patient Finder PAH(Oncology) Winrevair US: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Merck | Oncology & PAH | Keytruda & Winrevair | US (Copy) (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 2

[find-dm] Find DM: Suggested titles to target at Merck | Oncology & PAH | Keytruda & Winrevair | US (Copy): VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Novartis - Kesimpta (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Novartis: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer
[opportunity-intel] Opportunity: Novartis ianalumab (BAFF blockade) for Sjogren's. Relevance to Patient Finder: potential alignment with digital patient identification.

Otsuka - centanafadine (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Otsuka: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Patient Finder for Temple Health (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Randal Whitmore | Days silent: 160

[find-dm] Find DM: Suggested titles to target at Patient Finder for Temple Health: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Pfizer | ATTR-CM | DE (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Jacob Plummer | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Pfizer | ATTR-CM | DE: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Pfizer- Abrysvo (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Pfizer- Abrysvo: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Pfizer- Comirnaty (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Pfizer- Comirnaty: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Pfizer- Xtandi (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Pfizer- Xtandi: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Pharming | Joenja | Activated phosphoinositide 3-kinase delta syndrome (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Pharming | Joenja | Activated phosphoinositide 3-kinase delta syndrome: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Progyny | Endometriosis | US (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Jacob Plummer | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Progyny | Endometriosis | US: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Roche | Neurology & Oncology | Global (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Roche | Neurology & Oncology | Global: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Sanofi | Nexviazyme | Pompe's disease (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Sanofi | Nexviazyme | Pompe's disease: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Takeda - Eohilia (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Takeda: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Takeda - Oveporexton (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Takeda: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Takeda | Narcolepsy | investigational | US (€421,336) — Score: 842,673

Stage: Discovery | 10% | Assignee: Eran Desheh | Days silent: 4

[find-dm] Find DM: Suggested titles to target at Takeda | Narcolepsy | investigational | US: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

TAKEDA | Psoriasis & Psoriatic Arthritis (Phase 3)| US (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 23

[find-dm] Find DM: Suggested titles to target at TAKEDA | Psoriasis & Psoriatic Arthritis (Phase 3)| US: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Teva Pharmaceutical Industries | Austedo | Tardive dyskinesia (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 66

[find-dm] Find DM: Suggested titles to target at Teva Pharmaceutical Industries | Austedo | Tardive dyskinesia: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Tolmar - Fensolvi (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Usaid Cheema | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Tolmar: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Trinity Life Sciences Exploration (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Jacob Plummer | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Trinity Life Sciences Exploration: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

UCB | BIMZELX | HS |Ex-US (€421,336) — Score: 842,673

Stage: Discovery | 10% | Assignee: Jacob Plummer | Days silent: 12

[find-dm] Find DM: Suggested titles to target at UCB | BIMZELX | HS |Ex-US: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

UCB | Bimzelx | Psoriasis & HS (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Jacob Plummer | Days silent: 174

[find-dm] Find DM: Suggested titles to target at UCB | Bimzelx | Psoriasis & HS: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

UCB | TK2D | investigational | US (€421,336) — Score: 842,673

Stage: Discovery | 10% | Assignee: Jacob Plummer | Days silent: 12

[find-dm] Find DM: Suggested titles to target at UCB | TK2D | investigational | US: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

VERTEX | AMKD | US (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Ashley Cudini | Days silent: 23

[find-dm] Find DM: Suggested titles to target at VERTEX | AMKD | US: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Walgreens/Boots (€421,336) — Score: 842,673

Stage: Qualification | 5% | Assignee: Randal Whitmore | Days silent: 161

[find-dm] Find DM: Suggested titles to target at Walgreens/Boots: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Boehringer Ingelheim Jascayd Patient Finder (€421,336) — Score: 842,671

Stage: Discovery | 10% | Assignee: Karen VanOverberghe | Days silent: 4

[find-dm] Find DM: Suggested titles to target at Boehringer Ingelheim Jascayd Patient Finder: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Kings College London, Saudi Arabia (€402,511) — Score: 805,021

Stage: Proposal | 30% | Assignee: Adel Baluch | Days silent: 11

[find-dm] Find DM: Suggested titles to target at Kings College London, Saudi Arabia: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Ontario SOW10 Enhancement Opportunity - Condition Library - Planning and Development (€389,851) — Score: 779,703

Stage: Proposal | 30% | Assignee: Simon Wolpert | Days silent: 19

[find-dm] Find DM: Suggested titles to target at Ontario SOW10 Enhancement Opportunity: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Biogen Italy (€350,000) — Score: 700,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 5

[opportunity-intel] Opportunity: Biogen Italy litifilimab (anti-dendritic cell) for cutaneous lupus. Relevance to Patient Finder: potential alignment with digital patient identification.

Doctor Care Anywhere (€350,000) — Score: 700,000

Stage: Qualification | Assignee: Adel Baluch | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Doctor Care Anywhere: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Obeikan Health Care (€350,000) — Score: 700,000

Stage: Discovery | 10% | Assignee: Adel Baluch | Days silent: 11

[find-dm] Find DM: Suggested titles to target at Obeikan Health Care: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

PracticePlusGroup (€350,000) — Score: 700,000

Stage: Discovery | 10% | Assignee: Adel Baluch | Days silent: 6

[find-dm] Find DM: Suggested titles to target at PracticePlusGroup: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Ontario Enhancement - Health811 Post Login Experience (€309,406) — Score: 618,812

Stage: Discovery | 10% | Assignee: Simon Wolpert | Days silent: 19

[find-dm] Find DM: Suggested titles to target at Ontario Enhancement: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

BUPA UK (€300,000) — Score: 600,000

Stage: Contracting | 80% | Assignee: Johannes Vonhuelsen | Days silent: 14

[find-dm] Find DM: Suggested titles to target at BUPA UK: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Dronline (€300,000) — Score: 600,000

Stage: Discovery | 10% | Assignee: Adel Baluch | Days silent: 11

[find-dm] Find DM: Suggested titles to target at Dronline: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Janssen - Commercial Data Science (€300,000) — Score: 600,000

Stage: Qualification | Assignee: | Days silent: 1637

[find-dm] Find DM: Suggested titles to target at Janssen: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Aetna a CVS Health Company (€252,802) — Score: 505,604

Stage: Qualification | 5% | Assignee: Simon Wolpert | Days silent: 86

[find-dm] Find DM: Suggested titles to target at Aetna a CVS Health Company: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

BMS - Patient finder Camzyos (€250,000) — Score: 500,000

Stage: Discovery | 10% | Assignee: Eran Desheh | Days silent: 11

[find-dm] Find DM: Suggested titles to target at BMS: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

BMS Breyanzi Patient Finder (€250,000) — Score: 500,000

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 23

[find-dm] Find DM: Suggested titles to target at BMS Breyanzi Patient Finder: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Novartis Rhapsido (Hives no known triggers) Patient Finder (€250,000) — Score: 500,000

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 16

[re-engage] Re-engage: Novartis Rhapsido (Hives no known triggers) Patient Finder just ianalumab (BAFF blockade) for Sjogren's. Draft outreach?
[find-dm] Find DM: Suggested titles to target at Novartis Rhapsido (Hives no known triggers) Patient Finder: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Ontario Enhancements - Suicide Pop Up - Delivery (€247,525) — Score: 495,049

Stage: Qualification | 5% | Assignee: Simon Wolpert | Days silent: 271

[find-dm] Find DM: Suggested titles to target at Ontario Enhancements: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Ontario Enhancement - Gender Neutrality (€216,584) — Score: 433,168

Stage: Proposal | 30% | Assignee: Simon Wolpert | Days silent: 19

[find-dm] Find DM: Suggested titles to target at Ontario Enhancement: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Bayer Visanne Patient Finder (€211,510) — Score: 423,020

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 9

[find-dm] Find DM: Suggested titles to target at Bayer Visanne Patient Finder: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Amgen Ultrarare US -Actimmune (CGD) (€210,668) — Score: 421,336

Stage: Discovery | 10% | Assignee: Karen VanOverberghe | Days silent: 2

[find-dm] Find DM: Suggested titles to target at Amgen Ultrarare US -Actimmune (CGD): VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

BMS Portfolio Exploration Digital Health Team Patient Finder (€210,668) — Score: 421,336

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 23

[find-dm] Find DM: Suggested titles to target at BMS Portfolio Exploration Digital Health Team Patient Finder: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Eli Lilly and Company (€210,668) — Score: 421,336

Stage: Qualification | Assignee: Karen VanOverberghe | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Eli Lilly and Company: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

GSK Product Exploration (€210,668) — Score: 421,336

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 5

[find-dm] Find DM: Suggested titles to target at GSK Product Exploration: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Ipsen Patient Finder (€210,668) — Score: 421,336

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 9

[find-dm] Find DM: Suggested titles to target at Ipsen Patient Finder: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Lilly Kisunla Patient Finder (€210,668) — Score: 421,336

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 2

[find-dm] Find DM: Suggested titles to target at Lilly Kisunla Patient Finder: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Lilly Lilly Direct - Patient Finder (€210,668) — Score: 421,336

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 3

[find-dm] Find DM: Suggested titles to target at Lilly Lilly Direct: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Lilly Zepbound OSA Ptient Finder (€210,668) — Score: 421,336

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 24

[find-dm] Find DM: Suggested titles to target at Lilly Zepbound OSA Ptient Finder: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Novartis - Cosentyx (E2E Care Journey) (€210,668) — Score: 421,336

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 23

[re-engage] Re-engage: Novartis just ianalumab (BAFF blockade) for Sjogren's. Draft outreach?
[find-dm] Find DM: Suggested titles to target at Novartis: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Sumitomo-Gemtesa Patient FInder (€210,668) — Score: 421,336

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 3

[find-dm] Find DM: Suggested titles to target at Sumitomo-Gemtesa Patient FInder: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Merck Patient Finder Portfolio Exploration (€210,667) — Score: 421,335

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 2

[find-dm] Find DM: Suggested titles to target at Merck Patient Finder Portfolio Exploration: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Voramedic (€200,000) — Score: 400,000

Stage: Contracting | 80% | Assignee: Johannes Vonhuelsen | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Voramedic: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Ontario SOW 9 Enhancement - OHT Mapping - Planning Only (€123,762) — Score: 247,525

Stage: Proposal | 30% | Assignee: Simon Wolpert | Days silent: 19

[find-dm] Find DM: Suggested titles to target at Ontario SOW 9 Enhancement: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Novartis HS Italy Upsell (€105,000) — Score: 210,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 16

[re-engage] Re-engage: Novartis HS Italy Upsell just ianalumab (BAFF blockade) for Sjogren's. Draft outreach?
[find-dm] Find DM: Suggested titles to target at Novartis HS Italy Upsell: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Novartis HS Spain Upsell (€105,000) — Score: 210,000

Stage: Qualification | 5% | Assignee: Eran Desheh | Days silent: 16

[re-engage] Re-engage: Novartis HS Spain Upsell just ianalumab (BAFF blockade) for Sjogren's. Draft outreach?
[find-dm] Find DM: Suggested titles to target at Novartis HS Spain Upsell: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Ontario SOW9 Enhancement - Trusted User (Deferred Auth) - Planning Only (€100,000) — Score: 200,000

Stage: Discovery | 10% | Assignee: Simon Wolpert | Days silent: 19

[find-dm] Find DM: Suggested titles to target at Ontario SOW9 Enhancement: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Roche LatAm (€100,000) — Score: 200,000

Stage: Qualification | 5% | Assignee: Ashley Cudini | Days silent: 23

[find-dm] Find DM: Suggested titles to target at Roche LatAm: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Health 811 SOW9 - HCC + Survey Planning + Delivery (€92,822) — Score: 185,644

Stage: Proposal | 30% | Assignee: Simon Wolpert | Days silent: 153

[find-dm] Find DM: Suggested titles to target at Health 811 SOW9: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Relevate health (€84,267) — Score: 168,535

Stage: Discovery | 10% | Assignee: Jacob Plummer | Days silent: 3

[find-dm] Find DM: Suggested titles to target at Relevate health: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

MSD | PAH | SOTATERCEPT | DE (€50,000) — Score: 100,000

Stage: Contracting | 80% | Assignee: Eran Desheh | Days silent: 3

[find-dm] Find DM: Suggested titles to target at MSD | PAH | SOTATERCEPT | DE: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Ontario SOW9 - Health Care Connect (Primary Care Attachment) - Planning Only (€30,941) — Score: 61,881

Stage: Proposal | 30% | Assignee: Simon Wolpert | Days silent: 212

[find-dm] Find DM: Suggested titles to target at Ontario SOW9: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

BioMarin(Amicus purchased) - Galafold (Fabry) (€8,426) — Score: 16,852

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 60

[find-dm] Find DM: Suggested titles to target at BioMarin(Amicus purchased): VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Eli Lilly and Company (€8,426) — Score: 16,852

Stage: Qualification | Assignee: Karen VanOverberghe | Days silent: 0

[find-dm] Find DM: Suggested titles to target at Eli Lilly and Company: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

UCB Bimzelx (HS) Peer to Peer Engagement Patient Finder (€421) — Score: 843

Stage: Discovery | 10% | Assignee: Karen VanOverberghe | Days silent: 3

[find-dm] Find DM: Suggested titles to target at UCB Bimzelx (HS) Peer to Peer Engagement Patient Finder: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

UCB MG-Rare Patient Finder (€421) — Score: 843

Stage: Qualification | 5% | Assignee: Karen VanOverberghe | Days silent: 39

[find-dm] Find DM: Suggested titles to target at UCB MG-Rare Patient Finder: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Glenmark Pharma (€1) — Score: 2

Stage: Qualification | 5% | Assignee: Jacob Plummer | Days silent: 22

[find-dm] Find DM: Suggested titles to target at Glenmark Pharma: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Amazon Health Services | United States (€0) — Score: 0

Stage: Qualification | 5% | Assignee: Christine Minott | Days silent: 33

[find-dm] Find DM: Suggested titles to target at Amazon Health Services | United States: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Fedgroup (€0) — Score: 0

Stage: Qualification | Assignee: Johannes Vonhuelsen | Days silent: 212

[find-dm] Find DM: Suggested titles to target at Fedgroup: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

GHOL (€0) — Score: 0

Stage: Qualification | 5% | Assignee: Johannes Vonhuelsen | Days silent: 0

[find-dm] Find DM: Suggested titles to target at GHOL: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

GoodApple - Menopause RFP (€0) — Score: 0

Stage: Discovery | 10% | Assignee: Jacob Plummer | Days silent: 23

[find-dm] Find DM: Suggested titles to target at GoodApple: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

HCA-UK (€0) — Score: 0

Stage: Discovery | 10% | Assignee: Adel Baluch | Days silent: 11

[find-dm] Find DM: Suggested titles to target at HCA-UK: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Medgate (€0) — Score: 0

Stage: Qualification | Assignee: Daniel Nathrath | Days silent: 1910

[find-dm] Find DM: Suggested titles to target at Medgate: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Northwestern Medicine - International (€0) — Score: 0

Stage: Contracting | 80% | Assignee: Adel Baluch | Days silent: 37

[find-dm] Find DM: Suggested titles to target at Northwestern Medicine: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Patient Finder for Boots UK (€0) — Score: 0

Stage: Qualification | Assignee: Randal Whitmore | Days silent: 160

[find-dm] Find DM: Suggested titles to target at Patient Finder for Boots UK: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

Philipps-Universität Marburg / Universitätsklinikum Marburg (€0) — Score: 0

Stage: Qualification | 5% | Assignee: Johannes Vonhuelsen | Days silent: 2

[find-dm] Find DM: Suggested titles to target at Philipps-Universität Marburg / Universitätsklinikum Marburg: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

PROBTP Groupe (€0) — Score: 0

Stage: Qualification | Assignee: Johannes Vonhuelsen | Days silent: 76

[find-dm] Find DM: Suggested titles to target at PROBTP Groupe: VP/SVP Commercial, Head of Patient Services, Chief Digital Officer

243 deals with recommendations out of pipeline.